Astera Labs (ALAB) President & COO reports 49,361 pre-planned trust share sales
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Astera Labs, Inc. director and President/COO Gajendra Sanjay reported insider sales executed through estate-planning trusts. On May 7, 2026, trusts identified as "Trust 2" and "Trust 3" sold an aggregate of 49,361 shares of Common Stock in a series of open-market transactions under a pre-arranged Rule 10b5-1 trading plan adopted on December 2, 2025.
The reported weighted average sale prices span ranges disclosed in multiple footnotes, including transactions within bands such as $192.4400 to $193.4300 and up to higher ranges reflected in individual line items. Following these transactions, Sanjay continues to hold 1,531,301 shares directly, while the trusts still hold over 650,000 shares each. The filing states that the shares in Trust 2 and Trust 3 are owned directly by estate planning trusts, and Sanjay disclaims beneficial ownership except to the extent of any pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Pre-planned trust sales totaling 49,361 shares, with large direct holdings retained.
Gajendra Sanjay, a director and President/COO of Astera Labs, Inc., reported open-market sales of 49,361 shares of Common Stock on May 7, 2026. The transactions were executed by estate-planning vehicles labeled Trust 2 and Trust 3, not from his direct account.
A footnote states the sales occurred automatically under a Rule 10b5-1 trading plan adopted on December 2, 2025, indicating these disposals were pre-scheduled rather than opportunistic. The filing also specifies that these trusts are estate-planning trusts and that Sanjay disclaims beneficial ownership, except for any pecuniary interest.
After the sales, Sanjay still holds 1,531,301 shares directly, while each trust continues to own more than 650,000 shares. Given the pre-planned nature, the continued large positions, and the estate-planning context, this Form 4 typically reads as a routine diversification and planning step rather than a thesis-changing event.
Insider Trade Summary 10b5-1
Net Seller: 49,361 shares ($9,833,295)
Net Sell
24 txns
Insider
Gajendra Sanjay
Role
President and COO
Sold
49,361 shs ($9.83M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,182 | $199.8987 | $436K |
| Sale | Common Stock | 1,804 | $200.8614 | $362K |
| Sale | Common Stock | 1,696 | $202.0903 | $343K |
| Sale | Common Stock | 1,640 | $202.894 | $333K |
| Sale | Common Stock | 541 | $203.8927 | $110K |
| Sale | Common Stock | 586 | $205.2651 | $120K |
| Sale | Common Stock | 229 | $205.9442 | $47K |
| Sale | Common Stock | 683 | $213.49 | $146K |
| Sale | Common Stock | 946 | $193.0137 | $183K |
| Sale | Common Stock | 2,287 | $193.9543 | $444K |
| Sale | Common Stock | 3,104 | $194.9112 | $605K |
| Sale | Common Stock | 5,678 | $195.7393 | $1.11M |
| Sale | Common Stock | 913 | $196.9384 | $180K |
| Sale | Common Stock | 9,108 | $198.2063 | $1.81M |
| Sale | Common Stock | 8,603 | $198.8236 | $1.71M |
| Sale | Common Stock | 2,182 | $199.8986 | $436K |
| Sale | Common Stock | 1,804 | $200.8612 | $362K |
| Sale | Common Stock | 1,696 | $202.09 | $343K |
| Sale | Common Stock | 1,640 | $202.8936 | $333K |
| Sale | Common Stock | 541 | $203.8924 | $110K |
| Sale | Common Stock | 586 | $205.2642 | $120K |
| Sale | Common Stock | 230 | $205.9443 | $47K |
| Sale | Common Stock | 682 | $213.49 | $146K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 662,179 shares (Indirect, By Trust 2);
Common Stock — 1,531,301 shares (Direct, null)
Footnotes (1)
- The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $199.4500 to $200.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $200.4500 to $201.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $201.4600 to $202.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $202.5000 to $203.4600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $203.5000 to $204.4200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $204.6900 to $205.6000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $205.8400 to $206.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $192.4400 to $193.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $193.4500 to $194.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $194.4500 to $195.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $195.4500 to $196.4100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $196.4500 to $197.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $197.4500 to $198.4400, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $198.4500 to $199.4300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $204.6600 to $205.6000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Key Figures
Shares sold: 49,361 shares
Direct holdings after transaction: 1,531,301 shares
Trust 2 holdings after transaction: 662,179 shares
+4 more
7 metrics
Shares sold
49,361 shares
Aggregate open-market sales on May 7, 2026
Direct holdings after transaction
1,531,301 shares
Common Stock held directly by Gajendra Sanjay after sales
Trust 2 holdings after transaction
662,179 shares
Common Stock owned by estate-planning Trust 2 after sales
Trust 3 holdings after transaction
694,054 shares
Common Stock owned by estate-planning Trust 3 after sales
Highest listed sale price
$213.4900 per share
One of the open-market sale prices on May 7, 2026
Example price range (low band)
$192.4400–$193.4300
Weighted average price range from a disclosed transaction band
10b5-1 plan adoption date
December 2, 2025
Date the pre-arranged trading plan governing these sales was adopted
Key Terms
Rule 10b5-1 trading plan, weighted average price, estate planning trust, beneficial ownership, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 2, 2025"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
estate planning trust financial
"These shares are owned directly by an estate planning trust ("Trust 2")."
beneficial ownership regulatory
"The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 16 regulatory
"beneficial owner of these securities for purposes of Section 16 or for any other purpose"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
FAQ
What insider transactions did Astera Labs (ALAB) report for Gajendra Sanjay?
Astera Labs reported that entities associated with President and COO Gajendra Sanjay sold 49,361 shares of Common Stock on May 7, 2026. The sales were executed in multiple open-market trades through estate-planning trusts rather than from his direct personal holdings.
Were the Astera Labs (ALAB) insider sales by Gajendra Sanjay pre-planned?
Yes. A footnote explains the May 7, 2026 sales occurred automatically under a Rule 10b5-1 trading plan adopted on December 2, 2025. Such plans pre-schedule trades, making their timing less informative about the insider’s short-term view of the stock.
Does this Astera Labs (ALAB) Form 4 indicate any option exercises or derivative activity?
No. The transaction summary shows 49,361 shares sold and zero derivative exercises, gifts, tax-withholding entries, or restructuring transactions. The derivativeSummary section is empty, indicating no options or similar instruments were exercised in this specific filing.